Interaction between the Hepatitis C Virus and the Immune System

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Seminars in liver disease (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2000-9946PMID 10946419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection

  2004cited by this paper
• Comparative features of hepatitis C virus infection in humans and chimpanzees

  2004cited by this paper
• The pathology of viral hepatitis in chimpanzees

  2004cited by this paper
• Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.

  2000cited by this paper
• Cell mediated immune response to the hepatitis C virus.

  2000cited by this paper
• Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

  2000cited by this paper
• Viral clearance without destruction of infected cells during acute HBV infection.

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway

  1999cited by this paper
• Selective retention of activated CD8+ T cells by the normal liver.

  1999cited by this paper
• Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.

  1999cited by this paper
• Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response.

  1999cited by this paper
• Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

  1999cited by this paper
• Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

  1999cited by this paper
• Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.

  1999cited by this paper
• Control of early viral and bacterial distribution and disease by natural antibodies.

  1999cited by this paper
• An infectious molecular clone of a Japanese genotype 1b hepatitis C virus

  1999cited by this paper
• Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice

  1999cited by this paper
• Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.

  1999cited by this paper
• NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.

  1999cited by this paper
• Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus

  1999cited by this paper
• Analysis of a successful immune response against hepatitis C virus.

  1999cited by this paper
• Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy

  1999cited by this paper
• La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA

  1999cited by this paper
• Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.

  1999cited by this paper
• Mutations in the NS5A region do not predict interferon‐responsiveness in American patients infected with genotype 1b hepatitis C virus

  1999cited by this paper
• Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.

  1999cited by this paper
• Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver

  1999cited by this paper
• Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees

  1999cited by this paper
• Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.

  1999cited by this paper
• Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.

  1999cited by this paper
• Prometheus through the looking glass: reflections on the hepatic immune system.

  1999cited by this paper
• Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

  1999cited by this paper
• Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development

  1999cited by this paper
• Antiapoptotic and Oncogenic Potentials of Hepatitis C Virus Are Linked to Interferon Resistance by Viral Repression of the PKR Protein Kinase

  1999cited by this paper
• Binding of hepatitis C virus to CD81.

  1998cited by this paper
• Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

  1998cited by this paper
• β-Chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans

  1998cited by this paper
• Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice

  1998cited by this paper
• Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

  1998cited by this paper
• Does the hepatitis C virus replicate in cells of the hematopoietic lineage?

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• Analysis of Hepatitis C Virus-Inoculated Chimpanzees Reveals Unexpected Clinical Profiles

  1998cited by this paper
• Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations

  1998cited by this paper
• High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C

  1998cited by this paper
• Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes

  1998cited by this paper
• Immune Pathogenesis of Hepatocellular Carcinoma

  1998cited by this paper
• Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity.

  1998cited by this paper
• Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

  1998cited by this paper
• Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.

  1998cited by this paper
• Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.

  1998cited by this paper
• Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein*

  1998cited by this paper
• Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis

  1998cited by this paper
• Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent Pathways

  1998cited by this paper
• Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

  1998cited by this paper
• Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections.

  1998cited by this paper
• Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation

  1998cited by this paper
• Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C

  1998cited by this paper
• NK cell receptors.

  1998cited by this paper
• Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C

  1998cited by this paper
• The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

  1998cited by this paper
• Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.

  1998cited by this paper
• CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system.

  1998cited by this paper
• Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative‐strand viral rna in various tissues

  1998cited by this paper
• Internal Ribosome Entry Sites within the RNA Genomes of Hepatitis C Virus and Other Flaviviruses

  1997cited by this paper
• Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

  1997cited by this paper
• Analysis of T-cell receptor Vbeta repertoire in liver-infiltrating lymphocytes in chronic hepatitis C.

  1997cited by this paper
• Nitric oxide and macrophage function.

  1997cited by this paper
• Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon.

  1997cited by this paper
• Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection

  1997cited by this paper
• Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response.

  1997cited by this paper
• The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines.

  1997cited by this paper
• Hepatitis C virus core and E2 protein expression in transgenic mice

  1997cited by this paper
• Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor

  1997cited by this paper
• Transgenic expression of hepatitis C virus structural proteins in the mouse

  1997cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.

  1997cited by this paper
• Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon

  1997cited by this paper
• Interferons and Other Cytokines

  1997cited by this paper
• The origin of hepatitis C virus genotypes.

  1997cited by this paper
• Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus

  1997cited by this paper
• The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

  1997cited by this paper
• The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

  1997cited by this paper
• Combined liver and pancreas transplantation induces pancreas allograft tolerance.

  1997cited by this paper
• Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

  1997cited by this paper
• Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

  1997cited by this paper
• Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.

  1997cited by this paper
• Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis

  1997cited by this paper
• Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope

  1997cited by this paper
• Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.

  1997cited by this paper
• Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.

  1997cited by this paper
• Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

  1997cited by this paper
• Early antibody response against hypervariable region 1 is associated with acute self‐limiting infections of hepatitis C virus

  1997cited by this paper
• Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

  1997cited by this paper
• A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.

  1996cited by this paper
• Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

  1996cited by this paper

• Local and global stability of an HCV viral dynamics model with two routes of infection and adaptive immunity

  2023cites this paper
• Hepatitis C Patients with Progress of Disease Severity: Biochemical and Immunological studies

  2020cites this paper
• Understanding molecular pathogenesis: the biological basis of human disease and implications for improved treatment of human disease

  2020cites this paper
• Nanomedicine as a future therapeutic approach for Hepatitis C virus.

  2019cites this paper
• Interleukin 28B Polymorphism as a Predictor of Response to Treatment of Egyptian HCV Patients Working in Nuclear Material Authority

  2019cites this paper
• Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct‐acting anti‐viral therapy

  2018cites this paper
• Genetic epidemiology of Hepatitis C Virus infection outcome in Upper and lower Egypt: A multicenter Family based study

  2018cites this paper
• Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response

  2018cites this paper
• Polymorphism in interferon λ3/interleukin‐28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy

  2018cites this paper
• Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy

  2017cites this paper
• Drugs in Development for Hepatitis B

  2017cites this paper
• Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients

  2016cites this paper
• Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection

  2016cites this paper
• Hepatitis C virus‐cross‐reactive TCR gene‐modified T cells: a model for immunotherapy against diseases with genomic instability

  2016cites this paper
• Hepatitis C and hepatocellular carcinoma: A review of natural history

  2016cites this paper
• Hepatitis C virus: Why an Enigma?

  2016cites this paper
• Influence of IL10 Gene polymorphisms on the sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy.

  2016cites this paper
• Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients

  2016cites this paper
• Vasculitis related to viral and other microbial agents.

  2015cites this paper
• Análise de polimorfismos, expressão gênica e níveis séricos de IL-18, IL18BP e IFN-y na infecção crônica pelo HCV e resolução espontânea

  2015cites this paper
• Polymorphisms of IL-10 gene in patients infected with HCV under antiviral treatment in southern Brazil.

  2015cites this paper
• -137G>C Polymorphism in the Promoter Region of Il18gene is Associated with Serum Interleukin 18 (Il-18) Levels in Patients with Hepatitis C Virus Infection

  2015cites this paper
• Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients

  2015cites this paper
• Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology

  2015cites this paper
• Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection.

  2014cites this paper
• Long term changes in liver histology following treatment of chronic hepatitis C virus.

  2014cites this paper
• Endothelial Dysfunction in Patients with Chronic HCV Infection

  2014cites this paper
• Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy

  2014cites this paper
• Gut immune response in the presence of hepatitis C virus infection

  2014cites this paper
• 340 Long term changes in liver histology following treatment of chronic hepatitis C virus

  2014cites this paper
• A study of serum levels of B cell-attracting chemokine-13 (CXCL 13) and rheumatologic manifestations of chronic hepatitis C virus infection in a cohort of Egyptian patients

  2013cites this paper
• Relationship between Kuppfer cells, inflammation, and fibrosis in chronic hepatitis B and C.

  2013cites this paper
• População de células T CD8+ e Foxp3+ no líquen plano oral associado à infecção crônica de hepatite C

  2013cites this paper
• HCV viremia drives an increment of CD86 expression by myeloid dendritic cells

  2013cites this paper
• Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis B

  2012cites this paper
• Polymorphisms in interleukin‐10 and interleukin‐28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin‐therapy

  2012cites this paper
• Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C

  2012influential citation
• Regular Manuscript: PROTECTIVE EFFECT OF HLA-DRB1*11 AND PREDISPOSITION OF HLA-C*04 IN THE DEVELOPMENT OF SEVERE LIVER DAMAGE IN BRAZILIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

  2012cites this paper
• Drugs in Development for Hepatitis C

  2012cites this paper
• Is interleukin-10 gene polymorphism a predictive marker in HCV infection?

  2012cites this paper
• Protective Effect of HLA‐DRB1*11 and Predisposition of HLA‐C*04 in the Development of Severe Liver Damage in Brazilian Patients with Chronic Hepatitis C Virus Infection

  2012cites this paper
• Role of B-Cell-Attracting Chemokine-1 in HCV-Related Cryoglobulinemic Vasculitis

  2012cites this paper
• Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C.

  2012cites this paper
• The seroprevalence of anti-HCV in high-risk dialysis patients.

  2011cites this paper
• Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.

  2011cites this paper
• Aspergillosis of the Petrous Apex and Meckel's Cave.

  2010cites this paper
• Hepatitis C viral infection in a Chinese hemodialysis unit.

  2010cites this paper
• The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.

  2010cites this paper
• Transduction of Human T Cells with a Novel T-Cell Receptor Confers Anti-HCV Reactivity

  2010cites this paper
• Occult hepatitis C: How convincing are the current data?

  2009cites this paper
• Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells

  2009cites this paper
• Frequency of steatosis and its relation with the grade of fibrosis in patients with hepatitis C.

  2009cites this paper
• CLONING AND EXPRESSION STUDIES OF STRUCTURAL GENES OF PAKISTANI HEPATITIS C VIRUS GENOTYPE 3a

  2009cites this paper
• Severe insulin resistance in a treatment-naive chronic hepatitis C patient.

  2008cites this paper
• Hepatitis C virus and insulin resistance/diabetes mellitus.

  2008cites this paper
• Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.

  2008cites this paper
• Host Genetic Factors and Antiviral Immune Responses to HCV

  2008cites this paper
• cryoglobulinemia and correlate with active cutaneous vasculitis gene expression are distinctive features of HCV-related Increased serum levels of the chemokine CXCL13 and upregulation of its

  2008cites this paper
• Inhibition de la réception des signaux de danger via les TLR TRIF-dépendants dans les cellules dendritiques myéloïdes infectées avec le virus de l'hépatice C in vivo : mécanisme d'évasion de l'immunité innée dans l'infection chronique

  2008cites this paper
• EPIDEMIOLOGY OF CHRONIC HEPATITIS C VIRUS INFECTION IN HIGH RISK GROUPS

  2008cites this paper
• Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.

  2008cites this paper
• Host genetic factors and antiviral immune responses to hepatitis C virus.

  2008cites this paper
• Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia

  2008cites this paper
• The association between the genetic polymorphism of HLA‐DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population

  2008cites this paper
• Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis.

  2008cites this paper
• Clinical Spectrum of Hepatitis-Associated Cryoglobulinemia: Cross-Link between Hematological and Immunological Phenomena

  2007cites this paper
• Antiproliferative effect of hepatitis C virus on mitogen-stimulated peripheral blood mononuclear cells: potential role in viral persistence in Egyptian patients.

  2007cites this paper
• The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model

  2007cites this paper
• The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model

  2007cites this paper
• The Multifunctional Capsid Gene of Hepatitis C Virus

  2007cites this paper
• High levels of subgenomic HCV plasma RNA in immunosilent infections.

  2007cites this paper
• Hepatitis C virus core protein, lipid droplets and steatosis

  2007cites this paper
• Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus‐infected patients with and without mixed cryoglobulinaemia

  2006cites this paper
• Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C

  2006cites this paper
• Glucose Abnormalities in Patients With Hepatitis C Virus Infection: Epidemiology and Pathogenesis

  2006cites this paper
• Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response

  2006cites this paper
• Chronic Hepatitis C and Crohn’s Disease: Nosocomial Infection Treatment with PEG-Interferon plus Ribavirin

  2006cites this paper
• Increased hepatitis C virus (HCV)‐specific CD4+CD25 + regulatory T lymphocytes and reduced HCV‐specific CD4+ T cell response in HCV‐infected patients with normal versus abnormal alanine aminotransferase levels

  2006cites this paper
• Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse.

  2006cites this paper
• Novel approaches for therapy of chronic hepatitis C.

  2006cites this paper
• Identification of a hepatitis C virus–reactive T cell receptor that does not require CD8 for target cell recognition

  2006cites this paper
• Alanine transaminase levels in the year before pregnancy predict the risk of hepatitis C virus vertical transmission

  2006cites this paper
• Glucose Abnormalities in Patients with Hepatitis C Virus Infection

  2006cites this paper
• Analysis of protective cellular immune responses against hepatitis C virus.

  2006cites this paper
• Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse

  2006cites this paper
• Clinical Strategies for Chemoprevention of Liver Cancer

  2005cites this paper
• Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment.

  2005cites this paper
• Jak-STAT signaling in liver disease and repair : a way of living

  2005cites this paper
• Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1

  2005cites this paper
• Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection

  2005cites this paper
• Wide Range of Quasispecies Diversity during Primary Hepatitis C Virus Infection

  2005cites this paper
• Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.

  2005cites this paper
• Alteraciones hidrocarbonadas en los pacientes con infección crónica por el virus de la hepatitis C: estudio de prevalencia y de los mecanismos etiopatogénicos

  2005cites this paper
• Antigen location contributes to the pathological features of a transplanted heart graft.

  2004cites this paper
• Thymosin‐α 1 plus interferon‐α for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial

  2004cites this paper
• Virological, immunological and histological aspects in adult β‐thalassemic patients with chronic hepatitis C virus infection

  2004cites this paper
• Virus‐specific effector CD4+ T‐cell responses in hemodialysis patients with hepatitis C virus infection

  2004cites this paper
• MICA and recovery from hepatitis C virus and hepatitis B virus infections

  2004cites this paper
• Natural history of chronic hepatitis C in patients on hemodialysis: case control study with 4-23 years of follow-up.

  2004cites this paper
• Steatosis affects chronic hepatitis C progression in a genotype specific way

  2004cites this paper